Resources

By leveraging digital platforms, family planning programs can integrate new approaches that help reduce the costs, time, and inconvenience associated with traditional classroom training. PATH has recently developed digital training resources for health workers and clients learning to administer the injectable contraceptive, subcutaneous DMPA (DMPA-SC).A 10-lesson DMPA-SC eLearning course for health workers is available in English and French and can be taken on computer or mobile device with internet access. Content includes an emphasis on informed choice counseling, new lessons on calculating the injection date and conducting follow-up visits, and updated information on training clients to self-inject.In addition to the eLearning course, PATH and John Snow, Inc. have developed short 5- to 7-minute DMPA-SC training videos for both self-injection clients and health workers. Available in English and French, the videos can be translated or adapted to fit in program contexts.If you are interested in introducing DMPA-SC digital training approaches in your program, please contact FPoptions@path.org. For more information and resources, visit the DMPA-SC Resource Library.

Planning for and addressing supply chain challenges is part of achieving contraceptive security—ensuring clients can choose, access, and use family planning methods. This brief provides an overview of supply chain considerations for countries that are introducing or scaling up the injectable contraceptive subcutaneous DMPA (DMPA-SC) within the range of options available in their family planning programs.For more information, visit www.path.org/dmpa-sc, sign up for our newsletter, or email FPoptions@path.org.

The DMPA-SC Evidence to Practice meetings in 2018 and 2019 have gathered together family planning experts, including ministry officials, partners, and donors from more than 20 countries. Participants met to develop country strategies for increasing voluntary access to subcutaneous DMPA (DMPA-SC) within a wide range of contraceptive methods and to inform related policy decisions with current evidence. These reports summarize the plenaries, presentations, and discussions held to inform country planning. For more information, visit DMPA-SC Evidence to Practice: Increasing access, empowering women; sign up for our newsletter; or email FPoptions@path.org.

Subcutaneous DMPA (DMPA-SC, brand name Sayana® Press) is a new, easy-to-use injectable contraceptive that is ideally suited for remote access and even self-injection. The materials below are available in English and French. For more information, visit www.path.org/dmpa-sc, sign up for our newsletter, or email FPoptions@path.org.

This checklist is a customizable tool that can be used to monitor Subcutaneous DMPA (DMPA-SC, Sayana® Press) contraceptive self-injection programs and health worker practices. The questions can be adapted as needed to align with local program designs and guidelines. To access the MS Word version of this tool in English or French, please email FPoptions@path.org.DMPA-SC is an easy-to-use injectable contraceptive that is ideally suited for remote access and self-injection. For more information, visit www.path.org/dmpa-sc or sign up for our newsletter.